SIGN UP

Zachariah Reitano, Ro CEO

May 3, 2024 11:11 AM EDT

Digital health startup Ro’s CEO talks GLP-1 drug pricing, shortages and compounded shots

Shelby Livingston

Senior health tech reporter

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)

The fight to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

sponsored

Are programs with compounded GLP-1s safe for your population?